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Poly(ADP-ribose) polymerase-1 (PARP-1) is best characterised for its involvement in DNA repair. PARP-1
activity is also linked to cell fate, confounding its roles in maintaining genome integrity. The current
study assessed the functional roles of PARP-1 within human lens cells in response to oxidative stress. The
human lens epithelial cell line FHL124 and whole human lens cultures were used as experimental sys-
tems. Hydrogen peroxide (H2O2) was employed to induce oxidative stress and cell death was assessed by
LDH release. The functional inﬂuence of PARP-1 was assessed using targeted siRNA and chemical in-
hibition (by AG14361). Immunocytochemistry and western blotting were used to assess PARP-1 ex-
pression and the alkaline comet assay determined the levels of DNA strand breaks. PARP-1 was generally
observed in the cell nucleus in both the FHL124 cell line and whole human lenses. PARP-1 inhibition
rendered FHL124 cells more susceptible to H2O2-induced DNA strand breaks. Interestingly, reduction of
PARP-1 activity signiﬁcantly inhibited H2O2-induced cell death relative to control cells. Inhibition of
PARP-1 in whole human lenses resulted in a reduced level of lens opacity and cell death following ex-
posure to H2O2 relative to matched pair controls. Thus, we show that PARP-1 could play a role in the fate
of human lens cells, and these ﬁrst observations in human lenses suggest that it could impact on lens
opacity. Further studies are required to elucidate the regulatory processes that give rise to these effects.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Poly-ADP-ribose polymerases (PARPs) are a family of proteins
that are linked with a wide-range of DNA repair pathways [1–6].
Some PARPs have been identiﬁed as targets for therapeutics for
human diseases, particularly cancers [7–10]. However, a major
complexity in developing such compounds is that PARP enzymes
have multiple cellular roles, acting both in cell survival and in cell
death pathways [5,11]. In the current study, we used the human
lens as an experimental model to evaluate the physiological
functions of human PARP-1 in both cells and the organ.
The genomes of all cells are continually damaged in many
ways, by many agents. These can be external to the cell, for ex-
ample UV radiation from sunlight, and internal, such as chemicals
generated by normal cellular metabolism [12,13]. Such damage
can disrupt normal cellular metabolism, leading to mutations and
potentially cell death, and all cells have a complex of networks to
detect and correct damage to DNA. For example: Nucleotide Ex-
cision Repair (NER) repairs bulky lesions such as pyrimidineB.V. This is an open access article
er),dimers; Base Excision Repair (BER) repairs damage to bases; and
Non-homologous End-joining (NHEJ) repairs double-strand breaks
(DSBs) in the DNA backbone [12–14]. The human genome contains
150 different genes that are devoted to DNA repair processes
[15,16], whose importance is underscored by the debilitating
clinical symptoms that arise when these are defective [14]. Accu-
mulated DNA damage is also associated with natural ageing phe-
nomena [13,17]. The signiﬁcance of the relationship between DNA
damage/repair and human diseases was recognised in 2015 by the
award of the Nobel Prize in Chemistry to Tomas Lindahl, Aziz
Sancar, and Paul Modrich [18]. Thus, a detailed understanding of
DNA repair mechanisms will provide insights into biological pro-
cesses that are fundamental to improving lifelong health and
wellbeing in humans.
Through their roles in a wide-range of DNA repair pathways,
the PARP family of proteins are central to genome integrity
[3,4,19,20–23]. PARPs act to convert nicotinamide adenine dinu-
cleotide (NADþ) to ADP-ribose, catalysing addition of polymers of
ADP-ribose (PAR) to various nuclear acceptor proteins, including
histone, p53 and PARPs themselves [5,20,24,25]. Multiple PARPs
have been identiﬁed that have a well conserved catalytic domain
but have different structural domains and functions [3,4,20].
PARPs are divided into three groups: (i) PARPs 1–5, which are bona
ﬁde PARPs; (ii) PARPs 6–8, 10–12 and 14–16, which are conﬁrmedunder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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which are likely to be inactive because they lack key NADþ-
binding residues. PARP activities have been linked to diverse cel-
lular processes, including the response to DNA damage, chromatin
remodelling, transcriptional regulation, intracellular trafﬁcking,
telomere cohesion and energy metabolism [24,25]. Among the
PARP family members, PARPs 1–3 have been most widely studied
and they have well deﬁned roles in the DNA damage response, but
the cellular roles of other family members are incompletely un-
derstood [5,23]. These PARPs have been identiﬁed as targets for
potential therapeutics for human diseases, including cancer [7–
10]. However, clinical trials have provided conﬂicting data, leading
to re-evaluation of these therapies and highlighting that there is
still much to learn about the physiological roles of these proteins
in humans [5,25–27].
Genotoxic stress leads to PARP activation and various cellular
responses, including a decrease of levels of NADþ and increase of
levels of PAR. Through these biochemical activities the PARPs
dramatically inﬂuence the energy balance of cells and this may
provide a link to different physiological outcomes [3–5,21,23]. This
has led to the proposal that PARP-1 (at least) may act as a “cellular
rheostat” in relation to stress, promoting different cellular re-
sponses to various types and levels of stress signals [5]. Thus, as
the strength of the stress stimulus increases, the levels of PARP-1
activity and PAR synthesis increase, leading to different cellular
outcomes. Medium levels of PARP activity promote repair of DNA
damage, returning cells to homeostasis and genome stability.
When levels of DNA damage exceed repair capacity or there is
prolonged PARP activity, programmed cell death (PCD) is activated
to prevent cells from accumulating deleterious mutations. Apop-
tosis is a well-characterised mechanism of PCD that involves cas-
pases and other well-studied proteins such as p53 [13,14,17]. Due
to the activities of PARPs, extensive DNA damage is accompanied
by large-scale PAR synthesis that can lead to a unique form of cell
death, termed parthanatos. This triggers translocation of Apoptosis
Inducing Factor (AIF) to the nucleus where it mediates large-scale
DNA fragmentation and cell death [5,23]. PAR polymers deliver
different signals depending on their length and branching char-
acteristics and, thus, PARP activity acts as an elegant switch be-
tween DNA repair and induction of PCD [5,23]. There is growing
evidence that ageing in humans leads to higher levels of DNA
damage, which may be due to reduced effectiveness of DNA repair
processes [13,17,28,29]. Importantly, loss (or inhibition) of PARP
activity may lead to increased levels of DNA damage and reduced
amounts of PCD, including through parthanatos.
Although PARP function has been highly studied at an orga-
nismal level for some mammals, such as the mouse, the data is less
strong in humans, partly because knowledge about the number
and possible function of human PARPs is limited [3,20,23]. The
unique biology of the lens and its anatomical situation provides a
valuable human system to investigate PARP activity in relation to
DNA repair capability and tissue physiology. The lens is isolated
from other tissues and cells within the central anterior epithelium
have been present since lens vesicle formation during embry-
ogenesis. Moreover, both cell death and division are negligible in
this population [30]. Consequently, for very long timeframes these
cells are exposed to continuous stress, from UV exposure and
generation of metabolic products, and this is likely to impose a
signiﬁcant burden of biomolecular stress as the individual ages.
Indeed, recently we have used this system to demonstrate im-
portant links between oxidative stress, DNA repair systems and
the health of the lens [28,29]. We therefore employed a human
lens epithelial cell line (FHL124) and whole human lens organ
culture as experimental models to evaluate the physiological
functions of human PARP-1. We provide the ﬁrst conﬁrmation that
PARP-1 protein is expressed in the native human lens; in addition,expression in a lens cell line (FHL124) was also observed. More-
over, inhibition of PARP-1 protects FHL124 cells against H2O2-in-
duced cell death whilst rendering them more susceptible to per-
sistent DNA strand breaks. Most importantly, PARP-1 inhibition in
whole human lenses protects them from oxidative stress-induced
opacity and cell death, suggesting that this could provide a novel
target for therapies to suppress lens opacity and cataract
formation.2. Materials and methods
2.1. Cell culture
The FHL124 human lens epithelial cell line is a non-virally
transformed cell line generated from human capsule-epithelial
explants [31]. This cell line demonstrates a 99.5% homology to
native lens epithelium in transcript proﬁle [32]. FHL124 cells were
cultured at 35 °C with 5% CO2, 95% air in Eagle's Minimum Es-
sential Medium (EMEM) (Gibco, Paisley, UK) supplemented with
5% v/v foetal calf serum (FCS) (Gibco) and 50 μg/ml gentamcin
(Sigma-Aldrich, Dorset, UK). FHL124 cells were seeded onto
35 mm tissue culture dishes (35,000/dish for alkaline comet assay
and western blot) or 1818 class coverslips contained within
35 mm tissue culture dishes (10,000/coverslip for im-
munocytochemistry). The culture medium was replaced with
EMEM without FCS 24 h prior to addition (or start) of experi-
mental conditions.
2.2. Whole human lens culture
Donor eyes were obtained from the East Anglian Eye Bank with
written informed consent obtained from next of kin. The research
was approved by the UK National Research Ethics Committee (REC
04/Q0102/57) and followed the tenets of the Declaration of Hel-
sinki regarding the use of human donor material. Following re-
moval of cornea for transplant, lenses were dissected by anterior
approach and cultured within 24 h post-mortem as previously
described [33]. Brieﬂy, following dissection, lenses were main-
tained in EMEM supplemented with 50 μg/ml gentamicin at 35 °C,
5% CO2, 95% air for 24 h prior to addition of experimental condi-
tions to ensure no damage had arisen during dissection.
2.3. Chemical inhibition of PARP-1
PARP-1 was chemically inhibited with AG14361 (Selleck Che-
micals, Houston, TX, USA), a potent and speciﬁc inhibitor of PARP-
1 [34,35]. AG14361 was diluted in DMSO (Fisher Scientiﬁc,
Loughborough, UK) upon delivery to produce a 25 mM stock
which was frozen at 80 °C. All experiments therefore also con-
tained a dimethyl sulfoxide (DMSO) control diluted to the same
concentration. AG14361 was freshly diluted in serum-free EMEM
and added to FHL124 cells cultures to give a ﬁnal concentration of
1 mM. For experiments using whole human lenses, freshly diluted
AG14361 was added to whole human lens cultures to give a ﬁnal
concentration of 10 μM.
2.4. Knockdown of PARP-1 expression
Expression of PARP-1 was depleted in FHL124 cells using tar-
geted siRNA (Qiagen, Crawley, UK) with controls transfected with
AllStars Negative control siRNA (scramble siRNA) (Qiagen) using
oligofectamine transfection reagent (Invitrogen). All dilutions and
subsequent culture was performed in Opti-MEM. FHL124 cells
were transfected with siRNA at 5 nM for 48 h, after which cells
were either lysed for protein analysis by western blot, ﬁxed with
A.J.O. Smith et al. / Redox Biology 8 (2016) 354–3623564% formaldehyde for immunocytochemistry or treated (for analy-
sis of DNA strand breaks by alkaline comet assay).
2.5. Immunocytochemistry
Coverslips or tissue samples (isolated ﬂat mounted epithelium
from cultured lenses) were ﬁxed with 4% v/v formaldehyde (Sig-
ma-Aldrich) in PBS for 30 min followed by 3 washes in PBS for
5 min. Cells or tissue were permeabilised with 0.5% v/v Triton-x-
100 (Sigma-Aldrich) for 30 min. Three washes in PBS containing
0.02% w/v BSA and 0.05% v/v IGEPAL (Sigma-Aldrich) were per-
formed before blocking for non-speciﬁc binding sites with normal
donkey serum (1:50 in 1% w/v BSA in PBS) for 1 h. PARP-1 primary
antibody (Cell Signaling Technology, Danvers, MA, USA) was di-
luted (1:100 in 1% BSA in PBS) and applied overnight at 4 °C. Three
further washes in PBS containing 0.02% w/v BSA and 0.05% v/v
IGEPAL were performed followed by addition of secondary anti-
body (alexa488-conjugated donkey anti-rabbit (Invitrogen) di-
luted 1:100 in 1% BSA in PBS) for 1 h, protected from light at 37 °C
in a humidiﬁed atmosphere. Coverslips or tissue samples were
then counterstained with DAPI (Sigma-Aldrich) and Texas red-x-
phalloidin (Invitrogen). A further 3 washes in 0.02% w/v BSA and
0.05% v/v IGEPAL were performed followed by mounting of sam-
ples onto glass microscope slides. Samples were viewed with
ﬂuorescence microscopy (wideﬁeld microscope Zeiss AxioPlan 2ie,
Zeiss, Gottingen, Germany) and images captured with a digital
camera and AxioVision software (Zeiss). Image quantiﬁcation was
performed using ImageJ 1.45s image analysis software.
To establish cross-sections of the human lens, non-cultured
whole human lenses were ﬁxed in 4% v/v formaldehyde (Sigma-
Aldrich) in PBS, dehydrated in a graded alcohol series, cleared in
xylene and embedded in parafﬁn. Sections of lens (6 mm) were cut
and mounted on glass slides. Sections were deparafﬁnised in xy-
lene and rehydrated in descending ethanol concentrations and
then subjected to antigen retrieval in sodium citrate buffer (10 mM
sodium citrate, 0.05% Tween 20, pH 6.0) for 20 min. After three
washes in PBS for 5 min, sections were blocked in 10% normal
donkey serum in PBS for 1 h and then incubated with PARP-1
primary antibody (Cell Signaling Technology, Danvers, MA, USA)
diluted 1:400 in PBS overnight at 4 °C. Following three further
washes in PBS, sections were incubated with alexa488-conjugated
donkey anti-rabbit (Invitrogen) diluted 1:400 in PBS for 1 h pro-
tected from light. Sections were counterstained with DAPI, washed
once in PBS and mounted with a coverslip. Samples were viewed
with ﬂuorescence microscopy (wideﬁeld microscope Zeiss Ax-
ioPlan 2ie, Zeiss, Gottingen, Germany) and images captured with a
digital camera and AxioVision software (Zeiss, Cambridge, UK).
2.6. Western blot analysis
Cell lysates from FHL124 cells were prepared using M-PER
buffer (Thermo Scientiﬁc, Basingstoke, UK) supplemented with
phosphatase and protease inhibitors and 0.5 M EDTA (Thermo
Scientiﬁc) at 10 μl/ml immediately prior to use. Total protein
content was determined by the BCA assay (Pierce, Thermo Scien-
tiﬁc) to enable loading of equal amounts of protein per sample
onto 10% SDS-polyacrylamide gels. Proteins were transferred to
PVDF membrane using a semidry transfer cell. Membranes were
blocked with PBS containing 5% w/v non-fat dry milk and 0.1% v/v
Tween-20, hybridised with primary antibody against PARP-1 or β-
actin (Cell Signaling Technology), followed by incubation with
secondary antibody conjugated with horse radish peroxidase (GE
Healthcare, Little Chalfont, UK). Proteins were detected using the
ECL Plus Western Blotting Detection System (GE Healthcare).2.7. Alkaline comet assay
To assess levels of DNA strand breaks in FHL124 cells, the al-
kaline comet assay was performed. Brieﬂy, following experimental
treatments, cells were washed with ice cold PBS, harvested,
counted, re-suspended in PBS containing 10% DMSO and frozen at
80 °C until the alkaline comet assay was performed as pre-
viously described [28,29].
2.8. Measurement of cell death using the lactate dehydrogenase
(LDH) assay
At experimental end points, culture medium (of FHL124 cells
or whole human lenses) was sampled and assayed for LDH con-
tent as a measure of cell death using a Cytotoxicity Detection Kit
(LDH) (Roche, Mannheim, Germany) following the manufac-
turer's instructions. The amount of LDH present in culture med-
ium is proportional to the amount of dead or dying cells in a
population. Data was analysed as a percentage change of absor-
bance at 490 nm from untreated FHL124 cells or whole human
lenses
2.9. Analysis of human lenses for reduction in visual quality
Lenses were imaged using a charge coupled device (CCD)
camera (UVP, Cambridge, UK) with Synoptics software (Synoptics,
Cambridge, UK) at the experimental start point (day 0) and at 24 h
intervals throughout experiments. Brightﬁeld illumination was
used, with a black and white grid placed beneath lenses to give an
assessment of visual quality and therefore lens clarity. Visual
quality was quantiﬁed from these images by measuring standard
deviation values of grey scale values obtained from the grid be-
neath the lens. Values of standard deviation of clear lenses are
high whereas when the lens becomes more opaque, the grid be-
comes less deﬁned/homogenous and the standard deviation va-
lues decrease. A background for each image was achieved by se-
lecting a region of the grid adjacent to the lens. This region ex-
hibits the greatest standard deviation and best visual quality and
thus a decrease was calculated relative to these values. Image
analysis was performed with Image-Pro Premier (MediaCyber-
netics Inc., MD, USA) analysis software.3. Statistical analysis
One way analysis of variance (ANOVA) with posthoc Tukey's
test was performed to determine statistical differences between
multiple experimental groups (SPSS 16.0, SPSS Inc., IL, USA) and
Student's t-test to determine statistical differences between two
experimental groups (Excel, Microsoft, WA, USA). A p value of
r0.05 was considered signiﬁcant.4. Results
4.1. PARP-1 expression in human lens cells
To assess the expression of PARP-1 in FHL124 cells and native
human lens immunocytochemistry was performed (Fig. 1A and B).
An intense staining pattern for PARP-1 was observed in the nu-
clear region of both FHL124 cells and the native epithelium (Fig. 1A
and B). Newly laid lens ﬁbre cells also presented a predominantly
nuclear expression (Fig. 1B), but levels declined at a given point,
which seemed to precede changes in chromatin appearance that
could be attributed to lens ﬁbre cell de-nucleation (Fig. 1B).
Fig. 1. PARP-1 detection in human lens cells. (A) Fluorescent micrographs showing PARP-1 distribution in FHL124 cells and the native human lens epithelium. (B) PARP-1
expression in the lens epithelium and pre-denucleating lens ﬁbre cells. A strong nuclear expression of PARP-1 is observed in cells exhibiting typical nuclei. However, as ﬁbre
cells become more embedded in the lens, chromatin appears condensed and these cells do not exhibit PARP-1 (arrowed). The data presented are representative of four lenses
from individual donors that were sectioned and stained. As a point of reference a cross-sectional diagram of the lens has been included (adapted from Maidment et al. [44]).
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induced DNA strand breaks in FHL124 cells
PARP-1 has been clearly described as having important roles in
the repair of oxidative DNA damage and single strand break repair
via the BER pathway [1,6,36]. H2O2 is a pro-oxidant able to cause
oxidative stress and subsequent damage to DNA. To investigate the
role of PARP-1 in oxidative stress-induced DNA strand breaks and
their repair in human lens cells, a chemical inhibitor of PARP-1,
AG14361, was applied at a concentration of 1 mM to FHL124
cells for 1 h prior to treatment with 30 mM H2O2. DNA strand
breaks were measured over 24 h following treatment (Fig. 2).
A 1 mM AG14361 concentration applied to human cells has
been shown previously to inhibit PARP-1 activity by greater than
90% [34].
H2O2 treatment in FHL124 cells without PARP-1 inhibition
produced a peak level of DNA strand breaks at 0.5 h (76.872.0%
DNA in tail) following treatment, after which levels of DNA strandbreaks were shown to steadily decline over the 24 h studied. In
FHL124 cells pre-treated with PARP-1 inhibitor, these levels of
DNA strand breaks also peaked at 0.5 post-H2O2 treatment
(97.070.5% DNA in tail), but this peak was signiﬁcantly greater
than control cells without PARP-1 inhibition. In fact, for all mea-
surements with PARP-1 inhibited, levels of DNA strand breaks
generally remained elevated over the 24 h study period.
4.3. The effects of PARP-1 chemical inhibition on oxidative stress-
induced FHL124 cell death
To investigate the effects of PARP-1 inhibition on oxidative
stress-induced cell death and survival, FHL124 cells were pre-
treated with the PARP-1 chemical inhibitor, AG14361, followed by
H2O2 treatment and analysis of cell death and survival. On this
occasion FHL124 cells were treated with 0 or 100 mM H2O2, a
concentration chosen based upon previous work within our la-
boratory that was shown to induce death of these cells [33].
Fig. 2. Effect of PARP-1 inhibition on H2O2-induced DNA strand breaks. FHL124
cells were pre-treated with 1 mM AG14361 for one hour prior to treatment with
30 mM H2O2. Levels of DNA strand breaks (% DNA in tail) were measured by the
alkaline comet assay and compared to H2O2 treated cells without AG14361 pre-
treatment. Data presented is representative of three independent experiments each
with 100 comets scored7SEM. *Indicates signiﬁcant difference between experi-
mental conditions at the indicated time-point (pr0.05; ANOVA with posthoc Tu-
key's test).
Fig. 3. PARP-1 inhibition reduces H2O2-induced FHL124 cell lysis and death.
(A) FHL124 cells were pre-treated with 1 μM AG14361 before application of 100 μM
H2O2. LDH released into the medium was measured (as a marker of cell death) at
24 h (absorbance at 490 nm) and compared to cells without pre-treatment with
AG14361. (B) PARP-1 inhibitor (AG14361) is not a direct antioxidant. AG14361 and
H2O2 were added to FHL124 cells simultaneously. LDH release (absorbance at
490 nm) was measured 24 h posttreatment and compared to cells treated with
H2O2 alone. Data represent the mean of three independent experiments7SEM.
*Indicates signiﬁcant difference between experimental groups (pr0.05; ANOVA
with posthoc Tukey's test).
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experimental end point were assayed as a measure of cell death
(Fig. 3). At 24 post-H2O2 treatment, levels of LDH were sig-
niﬁcantly lower in FHL124 cells pre-treated with AG14361 com-
pared to those without (Fig. 3A). Levels of LDH were signiﬁcantly
elevated in culture medium of FHL124 cells treated with H2O2
alone, with a 109.6% increase noted compared to untreated cells.
FHL124 cells ﬁrst pre-treated with AG14361 prior to addition of
H2O2 demonstrated a 32.9% increase in LDH release following
H2O2 treatment compared to untreated cells. No changes in LDH
release were noted with inhibitor pre-treatment alone (Fig. 3A).
To address concerns that AG14361 could be directly acting as
an anti-oxidant against H2O2, experiments were undertaken
whereby AG14361 and H2O2 were added to FHL124 cells si-
multaneously; following 24 h LDH release was again measured
(Fig. 3B). No statistically signiﬁcant difference in LDH release was
observed between cells treated with AG14361 and H2O2 simulta-
neously and those treated with H2O2 alone (Fig. 3B).
In summary, analyses of survival and death of FHL124 cells
generated consistent ﬁndings. For cells treated with H2O2, pre-
treatment with the PARP-1 inhibitor AG14361 improved their
survival and reduced levels of cell death.
4.4. The effects of siRNA mediated PARP-1 knockdown on oxidative
stress-induced DNA strand breaks in FHL124 cells
To further establish the effect of PARP-1 expression on FHL124
cell responses to oxidative stress, PARP-1 was depleted with tar-
geted siRNA. Knockdown of PARP-1 was conﬁrmed by im-
munocytochemistry and western blotting (Fig. 4A–C). Quantiﬁca-
tion of PARP-1 western blotting demonstrated that PARP-1 was
signiﬁcantly depleted (77.773.3%) compared to cells transfected
with non-coding scramble control siRNA. This depletion in PARP-1
expression was in line with expectations provided by the
manufacturer.
To investigate the effect of PARP-1 depletion on oxidative
stress-induced DNA strand breaks, FHL124 cells were eithertransfected with PARP-1 siRNA or non-coding scramble control
siRNA and treated with 30 mM H2O2. The alkaline comet assay was
performed and levels of DNA strand breaks were measured over
24 h (Fig. 4D). FHL124 cells treated with non-coding scramble
siRNA demonstrated a peak level of DNA strand breaks at 0.5 post-
H2O2 treatment (23.472.1% DNA in tail) with levels steadily de-
creasing thereafter. Levels of DNA strand breaks in PARP-1
knockdown cells also peaked at 0.5 post-H2O2 treatment demon-
strating an increase in strand breaks observed in cells without
PARP-1 knockdown at the same time point (42.072.7% DNA in
tail). Importantly, the levels of strand breaks in PARP-1 knockdown
cells were signiﬁcantly elevated compared to cells treated with
scramble control siRNA cells at 0.5 and 1 post-H2O2 treatment
(Fig. 4D).
4.5. The effect of PARP-1 inhibition on oxidative stress-induced
changes in a whole lens culture model
To test the effect of PARP-1 inhibition on oxidative stress in-
duced changes in the human lens, a whole lens culture systemwas
Fig. 4. Effect of depleting PARP-1 on H2O2-induced DNA strand breaks. Targeted siRNA signiﬁcantly depletes PARP-1 expression in FHL124 cells. (A) Immunocytochemistry
demonstrating PARP-1 knockdown, (B) representative gel fromwestern blot and (C) quantiﬁcation of western blot data pooled from three independent experiments adjusted
for β-actin loading controls 7 standard error of the mean. *Indicates signiﬁcant difference (pr0.05; Student's t-test). (D) FHL124 cells were treated with siRNA targeted
against PARP-1 and treated with 30 mM H2O2. Levels of DNA strand breaks were measured by alkaline comet assay and compared to levels in FHL124 cells treated with non-
coding scramble control siRNA. Data presented is representative of three independent experiments each with 100 comets scored7SEM. *Indicates signiﬁcant difference
between experimental conditions (pr0.05; ANOVA with posthoc Tukey's test).
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occur over a lifetime ultimately giving rise to cataract formation.
Our model system applies an acute stress to dramatically induce
change to accelerate events and allows us to ascertain whether
molecules of interest, in this case a PARP-1 inhibitor, can counterthe effects of this insult. A 10 mM solution of AG14361 was applied
to the lenses for 1 h prior to treatment with 1 mM H2O2. A greater
concentration of AG14361 was used to inhibit PARP-1 activity in
these experiments compared to those using FHL124 cells for var-
ious reasons, including increased cell number and potential of the
Fig. 5. PARP-1 inhibition protects human lenses from oxidative stress induced
opacity and cell death. (A) Representative brightﬁeld images of human lenses over
time and (B) quantiﬁcation of visual quality at day 1. (C) LDH release measured at
the experimental end point (day 1). Whole human lenses were treated for 1 h with
10 mM AG14361 followed by the application of 1 mM H2O2 (Day 0) and maintained
for a 24 h culture period. Data pooled from three independent experiments7SEM.
*Indicates signiﬁcant differences between conditions (pr0.05; Student's t-test).
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were imaged (Fig. 5A) and changes in visual quality were quanti-
ﬁed from brightﬁeld images and compared to match paired con-
trols treated with H2O2 but without pre-treatment with AG14361
(Fig. 5B). Culture medium was also sampled and assayed for LDH
release at 24 h as a marker of cell death (Fig. 5C).At the experimental start point (day 0) lenses in both condi-
tions (1 mM H2O2 and 1 mM H2O2þ10 mM AG14361) were fun-
damentally clear. This is demonstrated by the grid beneath the
lenses being clearly visible and deﬁned in each instance (Fig. 5A).
At day 1, control lenses treated with H2O2 alone demonstrated a
marked decrease in visual quality, with the grid beneath the lens
being less visible and deﬁned; however lenses pre-treated with
AG14361 were protected from the effects of H2O2, with the grid
remaining visible and only a slight central opacity was noted
(Fig. 5A). Quantiﬁcation demonstrated a signiﬁcant protection in
visual quality compared to match paired controls without pre-
treatment with the PARP-1 inhibitor AG14361; 18.473.2% versus
3.771.4% reduction in visual quality respectively (Fig. 5B).
Pre-treatment with AG14361 also protected lenses from H2O2-
induced cell death. LDH release measured at the experimental end
point (day 1) was signiﬁcantly lower in culture medium sampled
from lenses pre-treated with AG14361 compared to lenses without
pre-treatment (Fig. 5C), with a 78.9% suppression in LDH release
noted.5. Discussion
We have demonstrated that PARP-1 can inﬂuence both DNA
damage and cell death in human lens cells and, thus, PARPs could
putatively affect lens maintenance and disease. The ﬁndings of the
current study have relevance to maintenance of the healthy hu-
man lens and the potential to form lens opacity, and demonstrate
a tractable model human cell and tissue system to further in-
vestigate links between PARP activity, DNA damage, and the health
of cells in general.
Previous work has identiﬁed PARP in rodent lens cells [37,38].
In the present study we have demonstrated PARP-1 expression in
the human lens cell line FHL124 and in the native human lens
epithelium, and in each instance this expression was pre-
dominantly nuclear. For the ﬁrst time, PARP-1 activity was in-
hibited in FHL124 lens cells with a speciﬁc and potent chemical
inhibitor, AG14361 [34,35] and by a targeted siRNA approach to
deplete PARP-1 expression in FHL124 cells. FHL124 cells pre-
treated with AG14361 or with knockdown of PARP-1 were found
to be more susceptible to oxidative stress-induced DNA strand
breaks, with increased sensitivity to H2O2-induced DNA strand
breaks from those treated with H2O2 alone. This combination of
results conﬁrms that effects observed with chemical inhibition of
PARP-1 are likely to not be due to a direct anti-oxidant effect, but
due to depleted PARP-1 function. Importantly, in both instances
repair of DNA strand breaks was eventually observed, which is
consistent with previous studies of DNA repair systems using this
cell line [28,29]. In summary, it is evident from these inhibition
and knockdown studies that functional PARP-1 has the potential to
inﬂuence the response to DNA damage in human lens cells, which
supports previous ﬁndings from a range of studies that have
highlighted the importance of PARPs in the response to DNA da-
mage [1–6]. It can be concluded that PARP-1 inhibition or reduc-
tion can render FHL124 cells more susceptible to oxidative stress-
induced DNA strand breaks.
The present study has also investigated the effect of PARP-1
inhibition on lens cell survival and death following oxidative in-
sult. Survival of FHL124 cells following H2O2 treatment was found
to be increased when PARP-1 was chemically inhibited, and con-
versely, this inhibition of PARP-1 afforded protection from oxida-
tive stress-induced cell death. On ﬁrst observation, this result is in
conﬂict with data suggesting PARP-1 inhibition renders lens cells
increasingly sensitive to DNA damage induced by H2O2. However,
PARP enzymes have been reported to play a dual role, such that
they can modulate cell death programmes in addition to their
A.J.O. Smith et al. / Redox Biology 8 (2016) 354–362 361well-established pro-survival roles, most notably in DNA repair
[23,39]. The current study has demonstrated that human lens cell
death can be mediated by PARP-1. However, the speciﬁc pathways
in lens cells have yet to be elucidated and this will form the basis
of future investigations. In particular, efforts will concentrate on
parthanatos whereby PARP-1 is proposed to mediate cell death in
response to DNA damage in an alternative pathway to cellular
energy depletion. Additional avenues of future investigation will
assess the role of PARP-1 in regulating p53 and NF-κB, which are
established proteins in cell fate determination [5]. Both are target
proteins of PARP-1 and their subcellular location is controlled by
the nuclear export protein Crm1; however, their poly(ADP-ribosyl)
ation by PARP-1 prevents interaction with Crm1 and their nuclear
export. Thus, nuclear accumulation is thought to occur, promoting
transcription of genes involved in the stress response and apop-
tosis [40]. Localisation of p53 and NF-κB could be studied under
conditions of cellular stress, and effects of inhibition of PARP-1
elucidated.
In the present study it became apparent that oxidative stress-
induced cell death could be suppressed by the inhibition of PARP-
1. Thus, experiments were undertaken to ensure that AG14361 was
not acting as a direct anti-oxidant. When AG14361 and H2O2 were
added simultaneously to cell culture no difference in cell death
was noted compared to H2O2 treatment alone, suggesting pre-in-
cubation with AG14361 was necessary to produce its inhibitory
effect. Crystallographic analysis of AG14361 binding to PARP-1
found it to bind to speciﬁc sites within its catalytic domain pro-
ducing a speciﬁc and potent inhibitory effect [34]. This concurs
with ﬁndings by other investigators that PARP inhibitors do not act
as direct antioxidants [41].
Ultimately, PARP-1 inhibition in the human lens suppressed
oxidative stress induced opacity. We assume that this beneﬁt is
afforded through protection of the epithelium, which ultimately
supports the ﬁbre cell population. Previous work in the rat has
demonstrated differing effects of PARP inhibition on catar-
actogenesis. Drel et al. [37] have shown that PARP inhibitors offer
some protection against cataract formation in streptozotocin-dia-
betic rats, which is consistent with the ﬁndings in this study. In
contrast Miki et al. [38] reported an acceleration of cataract for-
mation in MNU treated rats. Differences between these studies
and the results presented could be attributed to the species of
investigation, the mode of cell/DNA damage and the PARP in-
hibitors used for each study, which all differ. Further research is
needed to conﬁrm the mechanism(s) by which PARPs could in-
ﬂuence oxidative stress induced cataract in humans.
While not a primary focus of our study, the distribution pattern
of PARP-1 in lens ﬁbre cells revealed some interesting ﬁndings that
will be investigated further in future studies. The most newly
formed ﬁbre cells presented a strong staining pattern in the nu-
cleus, which reﬂected observations in the epithelial cell popula-
tion. The expression levels in the nuclei, however, are dramatically
reduced several layers towards the centre of the lens. This loss of
expression precedes a change in chromatin organisation that could
represent residual nucleoli [42] and we believe could be associated
with phased lens ﬁbre de-nucleation [30]. It may be hypothesised
that a controlled loss of DNA repair systems will promote DNA
damage and contribute to this process. Caspase-3 is also im-
plicated in the denucleation process [30] and PARP-1 is an estab-
lished substrate for this enzyme [43]. A key player in these
apoptotic pathways is p53 [30] and, as described earlier, p53 is a
target of PARP-1 [5] and thus its functional impact could at some
level be governed by PARP-1. Understanding the regulatory mo-
lecules that control PARP activity and establishing the targets of
PARP-1 could improve our knowledge of lens ﬁbre denucleation.
The ﬁndings in the current study therefore provide interesting
lines of investigation in the future.In summary, the current study investigated the role of PARP-1
inhibition on oxidative stress-induced changes in lens cells and
provides the ﬁrst indication that PARP-1 inhibition could supress
human lens opacity and decline in visual quality resulting from
oxidative stress. This inhibition also afforded protection against
cell death. This study lays the foundation to further understand
the regulatory functions of PARPs in a human cell and organ
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